Histologic features and MIB-1/Ki67 indices in atypical meningiomas (GII WHO)

被引:0
|
作者
Jozefowicz, Mateusz [1 ]
Papierz, Wielislaw [1 ]
机构
[1] Zaklad Patomorfol Katedry Patomorfol Uniw Medyczn, Ul Pomorska 251, PL-92213 Lodz, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2012年 / 12卷 / 02期
关键词
atypical meningiomas; benign meningiomas; histologic features; proliferative index;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical meningiomas are defined according WHO criteria as tumours characterized by: increased mitotic activity or three or more of the following histologic features: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, patternless or sheet like growth, and foci of "spontaneous" or "geographic" necrosis. It means, that those meningiomas which reveal only one or even two from above mentioned features are, according to WHO classification, still consistent with diagnosis of benign (GI WHO) tumours. Histologic slices from 65 atypical meningiomas were investigated and presence of each from those diagnostic histologic criteria which were mentioned above, were taken to account. Additionally, in the same way 59 benign meningiomas, which showed one or two histologic features characteristic for atypical type of the tumours, were analysed. In all cases immunohistochemical reaction with MIB-1 antibody was carried out and proliferating indices (PI) were established using image analysis computer system. Correlation between histologic criteria for atypical meningiomas and proliferating indices of the tumours was statistically estimated. We found a significant relationship between PI and mitotic activity, necrosis, small cells changes, patternless growth, nucleolies and number of histologic features that tumors present.
引用
收藏
页码:104 / 128
页数:25
相关论文
共 50 条
  • [41] Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
    Wakimoto, H
    Aoyagi, M
    Nakayama, T
    Nagashima, G
    Yamamoto, S
    Tamaki, M
    Hirakawa, K
    CANCER, 1996, 77 (02) : 373 - 380
  • [42] MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears
    Dalquen, P
    Baschiera, B
    Chaffard, R
    Dieterich, H
    Feichter, GE
    Kramer, K
    Torhorst, J
    ACTA CYTOLOGICA, 1997, 41 (02) : 229 - 237
  • [43] KI-67 ANTIBODIES (KI-S5, MIB-1, AND KI-67) IN BREAST CARCINOMAS - A BRIEF QUANTITATIVE COMPARISON
    MAURI, FA
    GIRLANDO, S
    DALLAPALMA, P
    BUFFA, G
    PERRONE, G
    DOGLIONI, C
    KREIPE, H
    BARBARESCHI, M
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 171 - 176
  • [44] Clinicopathologic Study of the MIB-1 Labeling Index (Ki67) and Postoperative Prognosis for Intraductal Papillary Mucinous Neoplasms and Ordinary Ductal Adenocarcinoma
    Takeshita, Akiko
    Kimura, Wataru
    Hirai, Ichiro
    Takasu, Naoki
    Moriya, Toshiyuki
    Tezuka, Koji
    Watanabe, Toshihiro
    PANCREAS, 2012, 41 (01) : 114 - 120
  • [45] High KI67 Labeling Index in Resected WHO Grade 1 Meningiomas Correlates With a Higher Rate of Recurrence
    Nowak, K.
    Casey, J.
    Chitale, A.
    Kalchman, I.
    Buss, E.
    Keith, S. W.
    Hegarty, S. E.
    Curtis, M.
    Solomides, C.
    Shi, W.
    Judy, K. D.
    Andrews, D. W.
    Farrell, C. J.
    Werner-Wasik, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E572 - E572
  • [46] Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.
    Suzuki S.
    Oka H.
    Kawano N.
    Tanaka S.
    Utsuki S.
    Fujii K.
    Brain Tumor Pathology, 2001, 18 (2) : 151 - 154
  • [47] What is better/reliable, mitosis counting or Ki67/MIB1 staining?
    Kriegsmann, Mark
    Warth, Arne
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 543 - 546
  • [48] Growth fraction determination in pulmonary hypoplasia using Ki-67 (MIB-1) antibody
    Thomas, PA
    Durbin, J
    Langston, C
    Raab, SS
    Jagirdar, J
    Greco, MA
    PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (05): : 745 - 753
  • [49] The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms
    Prayson, RA
    ADVANCES IN ANATOMIC PATHOLOGY, 2005, 12 (03) : 144 - 148
  • [50] Diagnostic relevance of MIB-1 (Ki-67) reactivity for the diagnosis of endocervical glandular lesions
    Leteurtre, E
    Boman, F
    Farine, MO
    Leroy, JL
    Gosselin, B
    ANNALES DE PATHOLOGIE, 1998, 18 (03) : 172 - 177